Inhibition of CD95 ligand-mediated inflammation

By Seino K.   Tun T.   Ohshima N.   Hamada H.   Yoshino K.   Ikeda S.   Fukunaga K.   Taniguchi H.   Takada Y.   Yuzawa K.   Otsuka M.   Todoroki T.   Fukao K.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2038-2039

Elsevier

Access to resources Recommend Favorite

Biological factors that affect CD95 ligand-mediated inflammation

By Seino K.   Ogino T.   Ju S.-T.   Hamada H.   Yagita H.   Okumura K.   Fukao K.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 893-895

Elsevier

Access to resources Recommend Favorite

CD4 + T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis

By Wilson A.  

International Immunology, Vol. 10, Iss. 8, 1998-08 ,pp. : 1149-1157

Oxford University Press

Access to resources Recommend Favorite

Allopeptide-mediated expression of endothelial Fas-Ligand (CD95L) in long-term tolerized heterotopic rat heart grafts

By Fandrich F.   Dresske B.   Lin X.   Huang D.S.   Zavazava N.   Henne-Bruns D.  

Transplantation Proceedings, Vol. 31, Iss. 3, 1999-05 ,pp. : 1558-1559

Elsevier

Access to resources Recommend Favorite

IFN-α enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells

By Luft T.  

International Immunology, Vol. 14, Iss. 4, 2002-04 ,pp. : 367-380

Oxford University Press

Access to resources Recommend Favorite